About C16 Biosciences
C16 Biosciences is a private company based in New York, New York. It has reported $28,949,409 raised in three offerings on Form D since November 2018. Its chief executive is Shara Ticku.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Feb 21, 2023 | Mar 22, 2023 | $4,984,415of $10.2M target | 17 | $293K | EquityRule 506(b) | Form D ↗ |
| Feb 14, 2020 | Mar 3, 2020amended Mar 11, 2020 | $19,999,994fully sold | 45 | $444K | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Aug 16, 2018 | Nov 21, 2018 | $3,965,000of $4.0M target | 33 | $120K | OptionsRule 506(b) | Form D ↗ |
| Total, three offerings | $28,949,409 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on C16 Biosciences's Form D filed Mar 22, 2023.
Earlier filings also listed David Heller (promoter, last listed Mar 2020) and Andrew Shumaker (director and promoter, last listed Nov 2018).